Dynamic bioactive bone graft material having an engineered porosity
The present disclosure relates to a dynamic bioactive bone graft material having an engineered porosity. In one embodiment, a bone graft material is provided having bioactive glass fibers arranged in a porous matrix that is moldable into a desired shape for implantation. The material can be substantially without additives and can include at least one nanofiber. The porous matrix may include a combination of one or more pore sizes including nanopores, macropores, mesopores, and micropores. In another embodiment, a bone graft implant is provided having a matrix comprising a plurality of overlapping and interlocking bioactive glass fibers, and having a distributed porosity based on a range of pores provided in the bioactive glass fibers. The distributed porosity can comprise a combination of macropores, mesopores, and micropores, and the matrix can be formable into a desired shape for implantation into a patient.
1. A method of treating a bone defect, comprising:
providing a bone graft material, the material comprising:
a porous matrix comprising a plurality of overlapping and interlocking bioactive glass fibers and bioactive glass particulates distributed throughout the fibers, the fibers and particulates each having varying diameters, and pores having a range of sizes defined by the spaces between said fibers and particulates, the varying diameters of the fibers and particulates controlling pore size and distribution of the range of pores and overall porosity of the matrix, the matrix further having a distributed porosity based on said range of sizes of the pores such that the matrix is configured for staged resorption, the pores comprising micropores and macropores;
forming an implant from the bone graft material, the implant being formed by shaping the material into a shape and size for insertion into the bone defect; and
implanting the formed implant into the bone defect.
2. The method of claim 1 , wherein the pores further comprise nanopores or mesopores.
3. The method of claim 1 , wherein the range of sizes of the pores is distributed based on a gradient across the matrix.
4. The method of claim 1 , wherein the fibers are randomly oriented.
5. The method of claim 1 , wherein the micropores range in diameter from about 1 micron to about 10 microns.
6. The method of claim 1 , wherein the macropores range in diameter from about 100 microns to about 1 millimeter.
7. The method of claim 1 , wherein the pores range in diameter from about 100 nanometers to about 1 millimeter.
8. The method of claim 1 , wherein the matrix is configured with a porosity of at least 30%.
9. The method of claim 1 , wherein the matrix is configured with a porosity of at least 95% prior to being shaped.
10. The method of claim 1 , wherein the matrix is configured with a porosity of at least 80% after being shaped.
11. The method of claim 1 , wherein the material further comprises a carrier material.
12. The method of claim 11 , wherein the carrier material comprises collagen.
13. The method of claim 1 , further having antimicrobial properties.
14. The method of claim 1 , further including an additive comprising a tricalcium phosphate, calcium phosphate, calcium sulfate, carboxymethycellulose, collagen, hydroxyapatite, antimicrobial, antiviral, vitamin, x-ray opacifier, medicine, calcium, trace element, metal, metal oxide, nutrient, or acid.
15. The method of claim 1 , further including an additive comprising silver, copper, strontium, magnesium or zinc.
16. The method of claim 1 , further including an additive comprising an organic acid.
17. The method of claim 1 , wherein the implant is shaped by molding the material in a mold tray.
18. The method of claim 1 , wherein the material is compressible.
19. The method of claim 1 , further including the step of adding a liquid to form a cohesive mass.
20. The method of claim 19 , wherein the liquid comprises blood, saline, glycerin, gelatin, plasma, or bone marrow.